BioVentrix Names Ralph Stephan von Bardeleben as Co- Principal Investigator of the REVIVE-HF Clinical Trial

Press/Media

Period6 Mar 2020

Media coverage

1

Media coverage

  • TitleBioVentrix Names Ralph Stephan von Bardeleben as Co- Principal Investigator of the REVIVE-HF Clinical Trial
    Media name/outletHealth & Beauty Close-Up(Close-up Media)
    Country/TerritoryUnited States
    Date6/03/20
    PersonsGregg Stone